90 related articles for article (PubMed ID: 23689515)
1. Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia.
Gachet S; Genescà E; Passaro D; Irigoyen M; Alcalde H; Clémenson C; Poglio S; Pflumio F; Janin A; Lasgi C; Dodier S; Soyer M; Duménil G; Ghysdael J
Leukemia; 2013 Dec; 27(12):2289-300. PubMed ID: 23689515
[TBL] [Abstract][Full Text] [Related]
2. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia.
Medyouf H; Alcalde H; Berthier C; Guillemin MC; dos Santos NR; Janin A; Decaudin D; de Thé H; Ghysdael J
Nat Med; 2007 Jun; 13(6):736-41. PubMed ID: 17515895
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.
Gerby B; Clappier E; Armstrong F; Deswarte C; Calvo J; Poglio S; Soulier J; Boissel N; Leblanc T; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
Leukemia; 2011 Aug; 25(8):1249-58. PubMed ID: 21566655
[TBL] [Abstract][Full Text] [Related]
5. NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.
Catherinet C; Passaro D; Gachet S; Medyouf H; Reynaud A; Lasgi C; Ghysdael J; Tran Quang C
PLoS One; 2021; 16(7):e0254184. PubMed ID: 34234374
[TBL] [Abstract][Full Text] [Related]
6. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM
Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia.
Evangelisti C; Ricci F; Tazzari P; Tabellini G; Battistelli M; Falcieri E; Chiarini F; Bortul R; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Martelli AM
Leukemia; 2011 May; 25(5):781-91. PubMed ID: 21331075
[TBL] [Abstract][Full Text] [Related]
8. NF-κB1 Regulates Immune Environment and Outcome of Notch-Dependent T-Cell Acute Lymphoblastic Leukemia.
Grazioli P; Orlando A; Giordano N; Noce C; Peruzzi G; Scafetta G; Screpanti I; Campese AF
Front Immunol; 2020; 11():541. PubMed ID: 32346377
[TBL] [Abstract][Full Text] [Related]
9. Distinct sensitivity of CD8+ CD4- and CD8+ CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model.
Zhang Y; Hua C; Cheng H; Wang W; Hao S; Xu J; Wang X; Gao Y; Zhu X; Cheng T; Yuan W
Leuk Res; 2013 Nov; 37(11):1592-601. PubMed ID: 24090996
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J
Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627
[TBL] [Abstract][Full Text] [Related]
11. Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia.
Stevanović S; Griffioen M; Nijmeijer BA; van Schie ML; Stumpf AN; Rutten CE; Willemze R; Falkenburg JH
Leukemia; 2012 Feb; 26(2):312-22. PubMed ID: 21860431
[TBL] [Abstract][Full Text] [Related]
12. Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia.
Evangelisti C; Ricci F; Tazzari P; Chiarini F; Battistelli M; Falcieri E; Ognibene A; Pagliaro P; Cocco L; McCubrey JA; Martelli AM
J Cell Physiol; 2011 Mar; 226(3):822-31. PubMed ID: 20857426
[TBL] [Abstract][Full Text] [Related]
13. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
[TBL] [Abstract][Full Text] [Related]
14. Disruption of T cell regulatory pathways is necessary for immunotherapeutic cure of T cell acute lymphoblastic leukemia in mice.
Fiorentino S; Chopin M; Dastot H; Boissel N; Reboul M; Legrès L; Janin A; Aplan P; Sigaux F; Regnault A
Eur Cytokine Netw; 2005 Dec; 16(4):300-8. PubMed ID: 16464745
[TBL] [Abstract][Full Text] [Related]
15. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of acute lymphoblastic leukemia.
Teitell MA; Pandolfi PP
Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
[TBL] [Abstract][Full Text] [Related]
17. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency.
Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM
Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882
[TBL] [Abstract][Full Text] [Related]
18. Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.
Dolcetti R; Giardini R; Doglioni C; Cariati R; Pomponi F; D'Orazi C; Rao S; Lazarovits AI; Butcher EC; Boiocchi M
Am J Pathol; 1997 May; 150(5):1595-605. PubMed ID: 9137086
[TBL] [Abstract][Full Text] [Related]
19. IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia Progression.
Rabe JL; Gardner L; Hunter R; Fonseca JA; Dougan J; Gearheart CM; Leibowitz MS; Lee-Miller C; Baturin D; Fosmire SP; Zelasko SE; Jones CL; Slansky JE; Rupji M; Dwivedi B; Henry CJ; Porter CC
Cancer Res; 2019 Jul; 79(14):3702-3713. PubMed ID: 31142509
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma.
Bradstock K; Bianchi A; Makrynikola V; Filshie R; Gottlieb D
Leukemia; 1996 May; 10(5):813-20. PubMed ID: 8656676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
